{"title":"Impact of the en face view for coronary cannulation after transcatheter aortic valve replacement.","authors":"Kentaro Mitsui, Kensuke Takagi, Yu Kataoka, Takashi Ikee, Kota Murai, Takamasa Iwai, Kenichiro Sawada, Hideo Matama, Satoshi Honda, Yoshiyuki Tomishima, Masashi Fujino, Kazuhiro Nakao, Shuichi Yoneda, Fumiyuki Otsuka, Yasuhide Asaumi, Kenichi Tsujita, Teruo Noguchi","doi":"10.1007/s12928-025-01112-x","DOIUrl":"10.1007/s12928-025-01112-x","url":null,"abstract":"<p><p>With the increasing number of transcatheter aortic valve replacements (TAVR) performed annually, coronary cannulation in post-TAVR patients has gained importance. The aim of this study was to investigate the effectiveness of the en face view for post-TAVR coronary cannulation. Between March 2015 and March 2024, we evaluated coronary cannulation based on the period when the en face view was initiated post-TAVR in December 2021. To assess the impact of the transcatheter heart valve on cannulation success, we excluded patients whose cannulation was conducted outside the stent frame. During the study period, 82 consecutive coronary cannulations were evaluated (en face era/pre-en face era = 47/35). Balloon-expandable valves were used in 48.8% of cases, and cannulation was performed in 31.7% of cases involving acute coronary syndromes. The overall cannulation success rate was 64.6%. Notably, the success rate was significantly higher during the en face era compared to the pre-en face era (78.7% vs. 45.7%, p = 0.003). Cannulation success was more frequently achieved during the en face era in both types of prostheses (self-expandable valve: 83.3% vs. 50.0%, p = 0.049; balloon-expandable valve: 75.9% vs. 36.4%, p = 0.03). Moreover, multivariate analysis identified the en face era as an independent predictor of cannulation success (adjusted odds ratio = 4.57, 95% confidence interval = 1.37-15.30, p = 0.01). The success rate of cannulation was significantly higher during the en face era. This study suggests that the en face view enhances the success rate of coronary cannulation, regardless of the prosthesis type.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"644-656"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Successful use of percutaneous reverse Fogarty technique for thromboembolic occlusion of the popliteal artery.","authors":"Takafumi Fujita, Makoto Sugihara, Kaori Mine, Tetsuo Hirata, Takashi Kuwano, Shin-Ichiro Miura","doi":"10.1007/s12928-025-01115-8","DOIUrl":"10.1007/s12928-025-01115-8","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"713-714"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143584784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Predictors of the diuretic response in acute decompensated heart failure patients with severe aortic stenosis: sub-analysis of the LOHAS registry.","authors":"Takuma Takada, Kentaro Jujo, Takuro Abe, Kensuke Shimazaki, Yugo Nara, Hirofumi Hioki, Hideyuki Kawashima, Akihisa Kataoka, Makoto Nakashima, Masanori Yamamoto, Kazuki Mizutani, Masaki Izumo, Gaku Nakazawa, Ken Kozuma, Katsumi Saito, Yusuke Watanabe","doi":"10.1007/s12928-025-01100-1","DOIUrl":"10.1007/s12928-025-01100-1","url":null,"abstract":"<p><p>For severe aortic stenosis (AS) patients awaiting valve replacement, managing acute decompensated heart failure (ADHF) is crucial due to poor prognosis. The LOHAS registry evaluated the effect of tolvaptan in patients (mean age: 85 years) with severe AS and ADHF, demonstrating stable hemodynamics and sufficient diuresis. We investigated predictors of rapid successful decongestion. In the LOHAS study, eligible patients received tolvaptan (7.5 mg) on day 1 plus standard ADHF treatments. Patients were divided based on decongestion achievement on day 4. Of 59 enrolled, 35 (59%) achieved decongestion (decongestion group), and 24 (41%) remained congested (congestion group). Changes in body weight, renal function, and hemodynamics were comparable between groups over the first 4 days. However, the maximum inferior vena cava (IVC) diameter at admission was significantly larger in the decongestion group than the congestion group (12.6 ± 6.3 vs. 7.6 ± 4.8 mm, p = 0.007). ROC analysis revealed a cut-off of 11 mm for maximum IVC diameter to predict decongestion on day 4 (AUC: 0.73, 95% CI 0.58-0.88). In-hospital mortality was lower in the decongestion group (0% vs. 13%, p = 0.06). In conclusion, in this high-risk severe AS and ADHF population, adding tolvaptan to standard therapy may rapidly improve decompensation if patients have a sufficiently expanded IVC at admission. Maximum IVC diameter could predict successful decongestion with tolvaptan.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"619-628"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143398054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Feasibility of optical coherence tomography-guided primary percutaneous coronary intervention for STEMI: all-comer ATLAS-OCT trial.","authors":"Kohei Wakabayashi, Taishi Yonetsu, Takuya Mizukami, Myong Hwa Yamamoto, Sakiko Yasuhara, Koki Shishido, Shigeru Saito, Nobuaki Kobayashi, Masamichi Takano, Eisuke Usui, Tsunekazu Kakuta, Yosuke Oishi, Seita Kondo, Tenjin Nishikura, Yoshiyasu Minami, Junya Ako, Toshitaka Okabe, Toru Naganuma, Satoru Mitomo, Sunao Nakamura, Takumi Higuma, Junya Shite, Amane Kozuki, Satoru Suwa, Teruyoshi Kume, Shiro Uemura, Genki Naruse, Hiroyuki Okura, Yosuke Yamakami, Hiroyuki Fujii, Shigeki Kimura, Masamichi Iwasaki, Makoto Araki, Tomoyo Sugiyama, Mamoru Nanasato, Tomotaka Dohi, Takashi Ashikaga, Hiroyoshi Mori, Teruo Sekimoto, Yoichiro Sugizaki, Hiromasa Otake, Toshiro Shinke","doi":"10.1007/s12928-025-01137-2","DOIUrl":"10.1007/s12928-025-01137-2","url":null,"abstract":"<p><p>Intravascular imaging for acute coronary syndrome is recommended in the guidelines; however, the actual rate of patients with ST-segment elevation myocardial infarction (STEMI) who successfully undergo optical coherence tomography (OCT)-guided primary percutaneous coronary intervention (PCI) is unclear. This study aimed to determine the feasibility of OCT-guided primary PCI and identify the patient population that would benefit most from OCT guidance in STEMI. The ATLAS-OCT trial was a prospective, single-arm, all-comers study conducted at 16 institutions. The primary endpoint was the feasibility of OCT guidance for primary PCI, defined as successful image acquisition (vessel's circumferential or > 270° visualization along > 70% of the lesion's length, as evaluated by an independent core laboratory). A total of 632 patients (mean age: 68.4 years; 80.2% male) were enrolled in the study. OCT-guided PCI was performed in 503 patients, whereas OCT guidance was avoided in 129 patients for patient's condition. Successful image acquisition was achieved in all but seven patients who underwent OCT. The primary endpoint was achieved in 78.5% (496/632) of patients. No procedural complications were associated with OCT. Patients with left main disease (adjusted odds ratio, 4.1; 95% confidence interval, 1.2-14.7; p = 0.024), estimated glomerular filtration rate (mL/min/1.73 m<sup>2</sup>) < 30 (3.7; 1.6-8.3; p = 0.002), and Killip IV (2.5; 1.3-4.6; p = 0.003) were significantly avoided for OCT guidance. OCT guidance was feasible in four-fifths of all-comers with STEMI. Further studies are warranted to evaluate the efficacy of OCT-guided PCI in selected patient populations based on the findings of this trial (UMIN000048590).</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"576-587"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Serial morphological and functional changes following intensive pharmacological intervention for left main disease.","authors":"Takayuki Warisawa, Susumu Katsushika, Yoshiki Kawai, Jiro Ando","doi":"10.1007/s12928-025-01102-z","DOIUrl":"10.1007/s12928-025-01102-z","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"703-704"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143467165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tetsuo Yamaguchi, Harindra C Wijeysundera, Sam Radhakrishnan
{"title":"Efficacy of cerebral embolic protection device in high-risk transcatheter aortic valve implantation.","authors":"Tetsuo Yamaguchi, Harindra C Wijeysundera, Sam Radhakrishnan","doi":"10.1007/s12928-025-01117-6","DOIUrl":"10.1007/s12928-025-01117-6","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"717-718"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143708703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Feasibility and safety of the distal radial access for vascular access interventional therapy.","authors":"Koji Kuroda, Ayaka Murakami, Takafumi Todoroki, Masamichi Iwasaki, Junichi Imanishi, Souichiro Yamashita, Wataru Fujimoto, Makoto Takemoto, Masanori Okuda","doi":"10.1007/s12928-025-01127-4","DOIUrl":"10.1007/s12928-025-01127-4","url":null,"abstract":"<p><p>Distal radial access (DRA) has emerged as an alternative approach to reduce the risk of radial artery occlusion in coronary angiography. Vascular access intervention therapy (VAIVT) is traditionally used to treat arteriovenous fistula stenosis. However, the feasibility and safety of DRA for VAIVT have not been established. This study aimed to evaluate the feasibility and safety of using DRA for VAIVT. We included 421 consecutive VAIVT procedures for upper limb arteriovenous fistulas retrospectively. DRA for VAIVT was performed in 181 procedures (DRA group), and the remaining procedures were approached through the brachial artery or vein (SA group: standard access group). Clinical follow-up was performed to evaluate the incidence of hematoma and dialysis access-associated steal syndrome (DASS). The mean follow-up duration following VAIVT was 24.0 months. The VAIVT success rate did not differ significantly between the groups (DRA: 97.8% vs. SA: 98.3%; P = 0.73), neither did the incidence of puncture site hematoma (DRA: 0.0% vs. SA: 0.8%; P = 0.51). There were no complications with DASS symptoms in the DRA group during the clinical follow-up. In the DRA group, 90 patients underwent a subsequent VAIVT procedure, and 85 patients (94.4%) underwent a subsequent VAIVT by DRA. DRA is a feasible and safe strategy for VAIVT and could be considered an option for VAIVT.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"599-606"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12167267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}